Health Science Authority
Home

Medicines

The Pharmaceuticals and Biologics Branch (PBB) and Generics and Biosimilars Branch (GBB) are responsible for the registration of medicines and the continual review of approved medicinal products. PBB and GBB will facilitate the timely introduction and availability of new and innovative quality medicines in Singapore and the region, including medicines targeted for diseases prevalent in the region.


The main activities relating to the control of medicinal products include:

  • Evaluation and approval of applications for new product licences, amendment and renewal of existing product licences, as well as the continual review of registered medicinal products.
  • Evaluation and approval for import of unregistered medicinal products on a named patient basis.
  • Approval for the import of medicinal products for the purpose of re-export.
  • Evaluation and approval of applications for licences for the purpose of importation of registered medicinal products on a per consignment basis.
  • Secretariat support for the Medicines Advisory Committee (MAC). 


Last updated on 18 May 2011 14:01:34
Best viewed using Internet Explorer 7.0 and above. | Privacy Statement | Terms of Use | HSA Data Protection Policy | Rate Our Website
Health Sciences Authority © 2007-2011. All Rights Reserved.